NCAM1 and neoplasm: Research has shown that RT can activate various immune responses, such as the recruitment of cytotoxic immune cells, including CD8 + T cells, NK cells, and CD8 + CD56 + natural killer T (NKT) cells, to the tumor microenvironment [28].